DOD Ovarian Cancer, Investigator-Initiated Research Award

The Department of Defense (DOD) is announcing the **Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award** for fiscal year 2025, with a funding opportunity number HT942525OCRPIIRA. This award aims to support innovative research that addresses significant needs in ovarian cancer care and has the potential for substantial contributions. Submissions are invited from both extramural and intramural organizations, including both for-profit and non-profit entities. Applications must focus on areas such as ovarian cancer biology, novel therapies, prevention strategies, early detection, and enhancing patient survivorship. Preliminary data is required to demonstrate the research's scientific validity. The application process is two-tiered: a pre-application due by June 12, 2025, followed by an invitation to submit the full application, which is due on September 11, 2025. The maximum funding for single Principal Investigators (PIs) is $1.05M, while partnering PIs can request up to $1.4M with a performance period of up to four years. Applications will undergo a rigorous peer review process assessing technical merit and programmatic relevance, with a response to funding recommendations expected by September 30, 2026. This program underlines DOD’s commitment to enhancing ovarian cancer research and care for service members and the broader community.